Heron Therapeutics, Inc.HRTXNASDAQ

Revenue (LTM)

$155M

+7.4% YoY

Net Income (LTM)

$-20M

-48.7% YoY

Free Cash Flow

$-28M

Revenue CAGR (5Y)

+11.8%

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	86	108↑24.7%	127↑18.0%	144↑13.6%	155↑7.4%
Gross Profit	40	53↑30.9%	62↑17.3%	106↑70.6%	114↑7.5%
Operating Income	-218	-175↑19.8%	-111↑36.7%	-12↑89.6%	-3↑78.0%
Net Income	-221	-182↑17.5%	-111↑39.3%	-14↑87.7%	-20↓48.7%
EBITDA	-215	-177↑17.9%	-104↑41.2%	-5↑95.1%	-18↓253.7%
EPS Diluted	-2.24	-1.67↑25.4%	-0.80↑52.1%	-0.09↑88.9%	-0.12↓34.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	91	15↓83.0%	29↑86.7%	26↓10.0%	29↑11.0%
Total Current Assets	254	205↓19.3%	189↓8.1%	209↑10.7%	238↑13.9%
Total Assets	306	251↓17.9%	223↓11.3%	233↑4.8%	256↑9.7%
Total Current Liabilities	71	82↑15.9%	80↓3.2%	91↑14.8%	96↑5.1%
Total Liabilities	228	237↑4.1%	256↑8.0%	267↑4.0%	242↓9.5%
Total Equity	78	14↓82.5%	-34↓350.3%	-34↑0.9%	14↑142.6%
Total Debt	159	157↓1.3%	180↑14.1%	178↓1.0%	141↓20.9%
Net Debt	69	142↑106.1%	151↑6.2%	152↑0.7%	112↓26.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-203	-147↑27.8%	-59↑60.0%	-23↑61.7%	-28↓22.5%
Capital Expenditure	-3	-2↑39.6%	-2↑15.3%	-2↓10.4%	-0↑81.4%
Free Cash Flow	-206	-149↑27.9%	-60↑59.4%	-24↑59.8%	-28↓15.2%
Stock-Based Comp	47	43↓8.3%	33↓23.6%	13↓60.5%	10↓20.2%
Net Change in Cash	-15	-75↓415.0%	13↑117.7%	-3↓121.6%	3↑199.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance